These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8929969)

  • 41. Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder.
    Frokjaer VG; Mortensen EL; Nielsen FA; Haugbol S; Pinborg LH; Adams KH; Svarer C; Hasselbalch SG; Holm S; Paulson OB; Knudsen GM
    Biol Psychiatry; 2008 Mar; 63(6):569-76. PubMed ID: 17884017
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 5HT2 receptor changes in major depression.
    Yates M; Leake A; Candy JM; Fairbairn AF; McKeith IG; Ferrier IN
    Biol Psychiatry; 1990 Mar; 27(5):489-96. PubMed ID: 2310804
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endogenous plasma estradiol in healthy men is positively correlated with cerebral cortical serotonin 2A receptor binding.
    Frokjaer VG; Erritzoe D; Juul A; Nielsen FA; Holst K; Svarer C; Madsen J; Paulson OB; Knudsen GM
    Psychoneuroendocrinology; 2010 Oct; 35(9):1311-20. PubMed ID: 20356681
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evolving knowledge of sex differences in brain structure, function, and chemistry.
    Cosgrove KP; Mazure CM; Staley JK
    Biol Psychiatry; 2007 Oct; 62(8):847-55. PubMed ID: 17544382
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cortical and subcortical 5-HT2A receptor binding in neuroleptic-naive first-episode schizophrenic patients.
    Erritzoe D; Rasmussen H; Kristiansen KT; Frokjaer VG; Haugbol S; Pinborg L; Baaré W; Svarer C; Madsen J; Lublin H; Knudsen GM; Glenthoj BY
    Neuropsychopharmacology; 2008 Sep; 33(10):2435-41. PubMed ID: 18288096
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Longitudinal assessment of cerebral 5-HT2A receptors in healthy elderly volunteers: an [18F]-altanserin PET study.
    Marner L; Knudsen GM; Haugbøl S; Holm S; Baaré W; Hasselbalch SG
    Eur J Nucl Med Mol Imaging; 2009 Feb; 36(2):287-93. PubMed ID: 18828013
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Direct comparison of [(18) F]MH.MZ and [(18) F] altanserin for 5-HT2A receptor imaging with PET.
    Hansen HD; Ettrup A; Herth MM; Dyssegaard A; Ratner C; Gillings N; Knudsen GM
    Synapse; 2013 Jun; 67(6):328-37. PubMed ID: 23390031
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [¹⁸F]Altanserin and small animal PET: impact of multidrug efflux transporters on ligand brain uptake and subsequent quantification of 5-HT₂A receptor densities in the rat brain.
    Kroll T; Elmenhorst D; Matusch A; Celik AA; Wedekind F; Weisshaupt A; Beer S; Bauer A
    Nucl Med Biol; 2014 Jan; 41(1):1-9. PubMed ID: 24120220
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Loss of serotonin 2A receptors exceeds loss of serotonergic projections in early Alzheimer's disease: a combined [11C]DASB and [18F]altanserin-PET study.
    Marner L; Frokjaer VG; Kalbitzer J; Lehel S; Madsen K; Baaré WF; Knudsen GM; Hasselbalch SG
    Neurobiol Aging; 2012 Mar; 33(3):479-87. PubMed ID: 20510480
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modeling [18 F]MPPF positron emission tomography kinetics for the determination of 5-hydroxytryptamine(1A) receptor concentration with multiinjection.
    Costes N; Merlet I; Zimmer L; Lavenne F; Cinotti L; Delforge J; Luxen A; Pujol JF; Le Bars D
    J Cereb Blood Flow Metab; 2002 Jun; 22(6):753-65. PubMed ID: 12045674
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Laterality and 5HT2 receptors in human brain.
    Yates M; Morris C; Cheng AV; Ferrier N
    Psychiatry Res; 1991 Feb; 36(2):169-74. PubMed ID: 2017531
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 5HT2A receptor binding is increased in borderline personality disorder.
    Soloff PH; Price JC; Meltzer CC; Fabio A; Frank GK; Kaye WH
    Biol Psychiatry; 2007 Sep; 62(6):580-7. PubMed ID: 17448449
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cerebral 5-HT2A receptor binding is increased in patients with Tourette's syndrome.
    Haugbøl S; Pinborg LH; Regeur L; Hansen ES; Bolwig TG; Nielsen FA; Svarer C; Skovgaard LT; Knudsen GM
    Int J Neuropsychopharmacol; 2007 Apr; 10(2):245-52. PubMed ID: 16945163
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serotonin 5-HT3 receptor binding kinetics in the cortex of suicide victims are normal.
    Mann JJ; Arango V; Henteleff RA; Lagattuta TF; Wong DT
    J Neural Transm (Vienna); 1996; 103(1-2):165-71. PubMed ID: 9026370
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Localization of serotonin 5-HT2 receptors in living human brain by positron emission tomography using N1-([11C]-methyl)-2-Br-LSD.
    Wong DF; Lever JR; Hartig PR; Dannals RF; Villemagne V; Hoffman BJ; Wilson AA; Ravert HT; Links JM; Scheffel U
    Synapse; 1987; 1(5):393-8. PubMed ID: 2905532
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Loss of brain 5-HT2 receptors in Alzheimer's disease. In vivo assessment with positron emission tomography and [18F]setoperone.
    Blin J; Baron JC; Dubois B; Crouzel C; Fiorelli M; Attar-Lévy D; Pillon B; Fournier D; Vidailhet M; Agid Y
    Brain; 1993 Jun; 116 ( Pt 3)():497-510. PubMed ID: 8513389
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estimation of neocortical serotonin-2 receptor binding potential by single-dose fluorine-18-setoperone kinetic PET data analysis.
    Petit-Taboué MC; Landeau B; Osmont A; Tillet I; Barré L; Baron JC
    J Nucl Med; 1996 Jan; 37(1):95-104. PubMed ID: 8544011
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [In vivo study of central serotoninergic receptors in man using positron tomography].
    Baron JC; Samson Y; Comar D; Crouzel C; Deniker P; Agid Y
    Rev Neurol (Paris); 1985; 141(8-9):537-45. PubMed ID: 2935920
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduction in serotonin 5HT2 receptor binding on platelets of delinquent adolescents.
    Blumensohn R; Ratzoni G; Weizman A; Israeli M; Greuner N; Apter A; Tyano S; Biegon A
    Psychopharmacology (Berl); 1995 Apr; 118(3):354-6. PubMed ID: 7617829
    [TBL] [Abstract][Full Text] [Related]  

  • 60. GMP-compliant radiosynthesis of [18F]altanserin and human plasma metabolite studies.
    Hasler F; Kuznetsova OF; Krasikova RN; Cservenyak T; Quednow BB; Vollenweider FX; Ametamey SM; Westera G
    Appl Radiat Isot; 2009 Apr; 67(4):598-601. PubMed ID: 19162492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.